Beckman Coulter Genomics and Genpathway are partnering to provide customers with whole-genome chromatin immunoprecipitation sequencing services, the companies said this week.
The new service, which is available worldwide, expands the DNA sequencing applications portfolio of Beckman Coulter Genomics, headquartered in Danvers, Mass.
Taking advantage of Genpathway's experience with ChIP, the service includes experimental design, antibody qualification, ChIP assays, next-generation sequencing, and data analysis.
Beckman Coulter Genomics, which provides genomic services as well as nucleic acid purification products, resulted from a merger of Beckman Coulter's Agencourt Biosciences with Cogenics last year.
Genpathway is an early-stage pharmacogenomics company providing drug and biomarker discovery and development services. The company uses a proprietary ChIP technology to understand gene regulation and genetic pathways.